Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
Prioritizing diseases for research and development in emergency contexts
Billions will not receive a COVID-19 vaccine in 2021
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
UK to 'look carefully' at claims vaccine efficacy in Israel has dropped to 33 per cent with one dose
U.K. begins large trial of new COVID-19 treatment inhaled into the lungs
Monoclonal antibodies: 'great hope' in Covid treatments fails against variants
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Covid: Vaccinated people may spread virus, says Van-Tam
Most poor nations 'will take until 2024 to achieve mass Covid-19 immunisation'
Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
Pfizer CEO vows to speed up vaccine development to under 100 days to combat the 'high likelihood' that current COVID-19 shots will need upgrades to stay effective
Coronavirus mutations add urgency to vaccination effort as experts warn of long battle ahead
High infection rate makes effort to contain Covid variants even more vital
SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Demonstrates Protective Immunity in Mice
Vaxart shares fall 42% on disclosure of early-stage results from COVID-19 vaccine study
GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once
Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study
A Nasal Spray for the Common Cold Is Closer to Reality
New Israeli Covid drug which cured 30 cases of disease hailed by scientists as 'huge breakthrough'
Oxford Covid jab less effective against South African variant, study finds
Washington Post - Opinion: A virus locomotive is heading straight at us
Why the U.S. Is Underestimating Covid Reinfection
Johnson & Johnson CEO: Annual COVID shots may be necessary in year's ahead
Scientists Urge For Investment Now In Highly Potent Vaccines To Prevent The Next Pandemic
Show your support for high-impact reporting
The coronavirus is going to stick around forever. Get ready for the new normal.
Antiseptic nasal sprays and mouthwash show promise in preventing COVID-19 infections
Intranasal Approaches Have Potential As Vaccines & Therapies for COVID-19
As Covid-19 Vaccines Raise Hope, Cold Reality Dawns That Illness Is Likely Here to Stay
Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677
Inhaling away the virus: Is the next generation of COVID vaccines on its way?
Aduro stung as Novartis drops work on STING drug
Antibody Resistance of SARS-CoV-2 Variants
As Covid-19 Vaccines Raise Hope, Cold Reality Dawns That Illness Is Likely Here to Stay
Immunome stock more than triples after isolating antibodies in treatment of COVID-19 variants
Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report
Where Are the Therapeutics to Combat COVID-19?
Altimmune's AdCOVID Vaccine Gets Positive FDA Update
Altimmune Video Presentation
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers
Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants
Coronavirus Variants and Mutations Tracker
Immunity to SARS-CoV-2 variants of concern
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
Moderna expects Phase 1 data for multivalent Coronavirus Vaccine sooner than May
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Pfizer in vaccine supply talks with India